Search results
PROMOTED
Start date:
Mar 26, 2024
Added:
3 years ago
Cardiovascular disease (CVD) is the leading cause of death worldwide. In the US, for example, CVD kills more men than the next seven causes of death combined, and more women than the next 16 causes of death combined. Some of the most dreaded effects of CVD result from atherosclerotic coronary artery disease (CAD) and its sequelae, including chronic angina, acute myocardial infarction (MI), heart…
View more
Added:
3 years ago
More than 10 million Americans suffer annually from angina.1 For decades, most of the attention has been focused on epicardial coronary artery disease (CAD). In a European registry of 11,000 stable angina patients, 65% of women and 32% of men had no obstructive CAD (<50% stenosis); however, multiple other studies have demonstrated only 30% of patients have significant obstructive epicardial…
View more
Added:
3 years ago
Cardiovascular disease (CVD) is the leading cause of death worldwide. In the US, for example, CVD kills more men than the next seven causes of death combined, and more women than the next 16 causes of death combined.1 Some of the most dreaded effects of CVD result from atherosclerotic coronary artery disease (CAD) and its sequelae, including chronic angina, acute myocardial infarction (MI), heart…
View more
Added:
5 years ago
Dr Philip Fischer discusses enabling outcome relevant decisions for coronary artery disease treatment.
Filmed byRadcliffe Cardiology on site at ESC 2018, Munich.
View more
Added:
3 years ago
The management of patients with stable coronary artery disease (CAD) is characterised by the utilisation of proven medical therapy and on-going effective risk stratification. Periodic assessment of patient symptomatology and functionality; evaluation and control of traditional risk factors; presence and extent of ischaemia; extent of CAD and left ventricular (LV) function; and referral to…
View more
Added:
3 years ago
The management of patients with stable coronary artery disease (CAD) is characterised by the utilisation of proven medical therapy and on-going effective risk stratification. Periodic assessment of patient symptomatology and functionality; evaluation and control of traditional risk factors; presence and extent of ischaemia; extent of CAD and left ventricular (LV) function; and referral to…
View more
Added:
3 years ago
Background
The management of patients with stable coronary artery disease (CAD) is characterised by the utilisation of proven medical therapy and on-going effective risk stratification. Periodic assessment of patient symptomatology and functionality; evaluation and control of traditional risk factors; presence and extent of ischaemia; extent of CAD and left ventricular (LV) function; and…
View more
Added:
2 years ago
TheInternational Cardio-Oncology Societyis a committed group of professionals throughout the world who are striving to protect the cardiovascular health of all patients who are undergoing cancer therapy. By optimising the cardiac status of patients with cancer before, during and after their treatment, IC-OS are collectively improving the overall outcomes including survival and quality of life. IC…
View more
Added:
3 years ago
Ischaemic heart disease (IHD) is the leading cause of morbidity and mortality worldwide. Two major pathways of disease development are acute coronary syndrome (ACS) and stable chronic angina.1,2 The success of prevention measures and early treatment pathways in ACS has helped to reduce the heart failure (HF) burden due to post-infarction remodelling and systolic dysfunction. However, accurately…
View more
